Back to Trades
Sloan Sheldon
Chief Medical OfficerCIK 0002038798
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 11
- Companies
- 1
- Active
- 2026
Across 5 filings between 2026, Sloan Sheldon, Chief Medical Officer, has disclosed $17.2M in transactions — all concentrated in Spyre Therapeutics, Inc. (SYRE). Their disclosed trades are heavily weighted toward selling — $0 in buys and $7.4M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jul 2 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon | Chief Medical Officer | Sell | $730.9K |
| Jun 3 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon | Chief Medical Officer | Sell | $625.0K |
| May 1 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon | Chief Medical Officer | Sell | $5.6M |
| Apr 3 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon | Chief Medical Officer | Sell | $397.9K |
| Jan 13 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon | Chief Medical Officer | Award | $4.3M |
5 filings